Immatics N.V. ( IMTX) - Stock Earnings
IMTX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 11, 2026, midnight | — / — | — | — / — | — |
IMTX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -59.3 million USD | 6.1 million USD |
| 2025Q4 | -41.9 million USD | 23.2 million USD |
| 2026Q1 | -66.3 million USD | 8.7 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
IMTX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -107.2 million USD | 59.7 million USD |
| 2024 | 15.8 million USD | 162.3 million USD |
| 2025 | -230.6 million USD | 56.7 million USD |
| 2026 Est. | — | — |
IMTX
Price: $9.44
52 week price:
Earnings Per Share: -1.95 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Germany
Volume: 207152
Market Capitalization: 1.3 billion